Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
CMS Decision Provides Supplemental Reimbursement to U.S. Hospitals for New Medical Device with Potential to Improve Outcomes for Patients Undergoing...
BRAINTREE, MA, March 9, 2015 /PRNewswire/ - Surgical Specialties Corporation, a leading provider of branded, private label , and OEM medical devices...
BRAINTREE, MA, Feb. 23, 2015 /PRNewswire/ - Angiotech Pharmaceuticals, Inc. announced today that K. Thomas Bailey has stepped down from the company's ...
BRAINTREE, MA and VANCOUVER, BC, Dec. 2, 2014 /PRNewswire/ - Surgical Specialties, Inc. announced today two important additions to its executive...
VANCOUVER, Oct. 9, 2014 /PRNewswire/ - Angiotech Pharmaceuticals, Inc. announced today that its Board of Directors has appointed John R. Barr as...
VANCOUVER, March 21, 2014 /PRNewswire/ - Angiotech Pharmaceuticals, Inc. ("ANPI") today announced its financial results for the quarter and year...
VANCOUVER, Oct. 11, 2013 /PRNewswire/ - Angiotech Pharmaceuticals, Inc. ("Angiotech") announced today that its shareholders and Board of Directors...
Private Call and Webcast Available Only to Shareholders of Record VANCOUVER, July 25, 2013 /PRNewswire/ - Angiotech Pharmaceuticals, Inc. will host a ...
VANCOUVER, May 31, 2013 /PRNewswire/ - Angiotech Pharmaceuticals, Inc. ("Angiotech") announced today that a return of capital will be provided to all ...
VANCOUVER, April 15, 2013 /PRNewswire/ - Angiotech Pharmaceuticals, Inc. ("Angiotech") announced that on April 12, 2013, Deutsche Bank National Trust ...
VANCOUVER, April 15, 2013 /PRNewswire/ - Angiotech Pharmaceuticals, Inc. ("Angiotech") announced today that on April 12, 2013 it completed its...
VANCOUVER, March 28, 2013 /PRNewswire/ - Angiotech Pharmaceuticals, Inc. ("Angiotech") announced that it released its financial results for the...
VANCOUVER, March 25, 2013 /PRNewswire/ - Angiotech Pharmaceuticals, Inc. ("Angiotech") announced today that it had entered into a definitive...
VANCOUVER, March 18, 2013 /PRNewswire/ - Angiotech Pharmaceuticals, Inc. will host a conference call discussing its financial results for the fourth...
VANCOUVER, March 18, 2013 /PRNewswire/ - Angiotech Pharmaceuticals, Inc. ("Angiotech") announced that today, Deutsche Bank National Trust Company...
VANCOUVER, Dec. 20, 2012 /PRNewswire/ - Angiotech Pharmaceuticals, Inc. ("Angiotech") announced today that it received approval on December 19, 2012...
VANCOUVER, Nov. 16, 2012 /PRNewswire/ - Angiotech Pharmaceuticals, Inc. ("Angiotech") announced that its partner Cook Medical, Inc. ("Cook") received ...
VANCOUVER, Nov. 14, 2012 /PRNewswire/ - Angiotech Pharmaceuticals, Inc. ("Angiotech") announced that it released its financial results for the third...
Third Quarter 2012 Financial Results VANCOUVER, Nov. 1, 2012 /PRNewswire/ - Angiotech Pharmaceuticals, Inc. will host a conference call discussing...
VANCOUVER, Sept. 18, 2012 /PRNewswire/ - Angiotech Pharmaceuticals, Inc. ("Angiotech") announced that on September 17, 2012, Deutsche Bank National...
VANCOUVER, Aug. 14, 2012 /PRNewswire/ - Angiotech Pharmaceuticals, Inc. ("Angiotech") announced that it released its financial results for the second ...
VANCOUVER, Aug. 10, 2012 /PRNewswire/ - Angiotech Pharmaceuticals, Inc. ("Angiotech") announced today the expiration of the offer by its subsidiary,...
Second Quarter 2012 Financial Results VANCOUVER, Aug. 1, 2012 /PRNewswire/ - Angiotech Pharmaceuticals, Inc. will host a conference call discussing...
Increased Maximum Exchange Offer Size: $225 Million Updated Expiration Time: 11:59 P.m., New York City Time, August 9, 2012 VANCOUVER, July 27, 2012...
VANCOUVER, July 3, 2012 /PRNewswire/ - Angiotech Pharmaceuticals, Inc. ("Angiotech") announced today that it has commenced an offer to exchange (the...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.